Swiss dental implants maker Straumann (STMN.S) reported half-year sales broadly in line with market expectations and confirmed its annual guidance on Wednesday.
The company's revenue grew to 1.38 billion Swiss francs ($1.70 billion) in the first half of 2026, compared with 1.35 billion francs a year ago and analysts' average estimate of 1.37 billion francs in a Vara consensus.
($1 = 0.8110 Swiss francs)
